Events

Save the Date – COMPAR-EU Final Conference Advocacy Event The European Patients’ Forum is pleased to announce that it will host the COMPAR-EU Final Conference Advocacy Event, to mark the end of the project. This advocacy conference marks the culmination of 5 years of interdisciplinary work to identify, compare, and rank the most effective and cost-effective self-management interventions for […]

The President of WFIPP, Mary Lynne van Poelgeest, will be participating in this Summit in her role as Co-Chair of the EU Health Coalition. The event will build on the stark lessons learned from COVID-19 and discuss how to go beyond the status-quo in health, seizing opportunities to make positive changes. It will ask what […]

EPF is pleased to invite you to the EU Legislation on AI webinar on Friday 28 October at 14:30 CEST. Register here! EU Legislation on AI The EU Legislation on AI webinar will feature Hannah van Kolfschooten, PhD researcher and lecturer in International and European Health Law at University of Amsterdam, and Mahsa Shabani, assistant professor in Privacy […]

The EAU Section of Genito-Urinary Reconstructive Surgeons (ESGURS) is holding the 12th edition of its Section Meeting in Madrid, Spain from 20-21 October, 2022. The meeting will be held in conjunction with the ESU-ESAU-ESGURS Masterclass on Erectile Restoration and Peyronie’s disease, held on 19-20 October. (For more details, see below!)

Our president Lynne van Poelgeest will be one of the speakers at the World Drug Safety Congress Europe 2022 in Amsterdam

The Czech National Association of Patient Organizations (NAPO) is taking the opportunity of the Czech presidency of the Council of the EU and organizes an international conference in Prague titled “Involving Patient Organizations in Health Policy Decision-Making”. Representatives of European patient organizations, Czech public health institutions and other stakeholders will explore the future role of patient organizations […]

Save the Date! Join us for ICS 2022 in Vienna, 7-10th September 2022. Abstract & Workshop Submission Centres will open 1st February and close 4th April 2022 23:59 BST (GMT +1 hr)

Ready for a unique summer conference vibe in Amsterdam? A city world famous for its canals, colourful cultural life and rich history. All-in-all, a great destination for the 37th Annual EAU Congress from 1 to 4 July.

With the latest in science and education, EAU22 will include live surgeries, challenging state-of-the-art lectures, hands-on training and late-breaking urology research.

Don’t miss out on the discounted late fee registration, which has now been extended until 15 June 2022 (23:59 CEST).

On the launch of the “incontinence thematic Innovation Ecosystem”.

RNA therapeutics are a new class of medicines that have a broad applicability targeting disease relevant proteins. Proteins are large and complex molecules that play a critical role in the body’s capacity to be healthy. Currently, most approved drugs are small molecules and protein biologics, which can only target a very limited number of proteins or genes. Our RNA-based therapeutics can be used to selectively trigger protein overexpression or downregulation, for single or multiple protein targets with one RNA construct. This uncovers new therapeutic possibilities for previously undruggable targets.

THURSDAY 23rd JUNE 2022 – 15.30-16.30 HRS (CET) Jiri Vermeulen, Wilfried Woesthuis, Minze Health and Prof. Stefan De Wachter, urologist at the University Hospital in Antwerp The automated bladder diary is a product intended to increase the patient compliance, usability and reliability of bladder diaries. Bladder diaries are an important tool ideally used throughout the […]

SAVE THE DATE – The EPF Congress 2022 will be back on 23-24 June
The European Patients’ Forum is pleased to announce the EPF Congress 2022 – Continuing the conversation on digital transformation will be held on 23 and 24 June 2022 in a live-streamed format.

Novuqare works together with healthcare professionals and patients on research and projects to initiate innovations and to develop clinically relevant healthcare solutions. Since their founding in 2011 they have developed long-term collaborations with several renowned healthcare partners. Their mission is to improve the care and health of patients by developing unique, innovative, medical-technological applications and services.

Tilla Care’s Cap Female Kit, including all the accessories (extension tube, lubricant gel, securement device and alcohol pads) has been developed by TillaCare Ltd., Israel. The UriCap is intended to be used as an external urine collection system for incontinent elderly women and can in many cases replace incontinence pads and invasive catheters.

Muvon Therapeutics have developed a highly innovative technology offering patients a minimally invasive, low-risk procedure (according to phase I data) in an outpatient setting. Potentially this procedure could prove a life changer and be long-lasting.

Subject: the role of Sacral Neuromodulation (SNM) in the management of pelvic floor dysfunction, whereby Dr. Grilo will explain what Sacral Neuromodulation is, the indications and the results. Laura Thomas will talk about patient expectations, patient education and patient follow-up. Finally, a patient?? will say something about his/her experience (from diagnosis to SNM treatment).